Patent · US Active

Extended release biodegradable ocular implants

US8685435B2 · kind B2 · utility

43Cited by

23References

2Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Thierry Nivaggioli · San Francisco, US
Jane-Guo Shiah · Irvine, US
Qing Lin · San Diego, US

Key dates

Filing date	Apr 30, 2004
Grant date	Apr 1, 2014
Priority date	—
Expiry date	Mar 21, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/204
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.